HealthLynked Closes Acquisition of Hughes Center Functional Medicine

NEXT STORY
Results of Single Center Prospective Study on Delcath’s PHP Therapy Presented at ECIO 2019
PREV STORY
CureVac Granted Patent Claiming the Combination of mRNA Vaccines with Anti-PD-L1 Antibodies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

United States Microbiology Markets 2019-2024 – Emerging Opportunities for New Instrumentation, Reagents Kits, & IT

author_avatar
NASDAQ Market News

Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer

author_avatar
NASDAQ Market News

Roche presents new data from its bispecific antibody portfolio across a range of blood cancers

author_avatar
NASDAQ Market News